Search results for: France
Filter search results
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
1 March 2017
…marketing authorisation in the EU. These OMPs are most widely accessible in Germany and France. In the other countries between 30% and 60% of OMPs are reimbursed. In England, less…
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
…Excellence (NICE) decision outcomes on healthcare decision-making in 12 countries across the globe (Australia, Brazil, Canada, France, Italy, Israel, Japan, South Korea, Poland, Saudi Arabia, Sweden, and the United Arab…
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
…in a selection of industrialised countries: Australia, Canada, France, Scotland, and the United Kingdom (England and Wales). The aims of the study are to identify the key determinants of decisions…
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…Considered in Healthcare Decision-making? An overview from other countries from Office of Health Economics There were three further presentations at the conference given by: Professor Francesco Saverio Mennini, President of…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…France, Germany, Italy, Spain and the UK. The “debate” around IBP centres on i) who benefits and who loses? and ii) how and whether it can be implemented in…
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
7 October 2019
…This research involved survey participants from the United Kingdom (UK), Germany, Spain, France, the Netherlands, Greece, and Italy who had used antibiotics in the previous two years. This is the…
The Expanding Value Footprint of Oncology Treatments
1 May 2014
…treatment regimen, or patient population or subpopulation. The decisions of three entities were included in the study: the Haute Autorité de Santé (HAS) in France, NICE in England and Wales,…
Politics of Prescribing
1 January 1985
…pharmaceutical innovation. The other six are the United States, West Germany, Switzerland, France,… This briefing is based on a lecture given by George Teeling Smith. At present Britain is one…
AIDS: Worldwide Policies and Problems
1 September 1991
The condition which was later to be called AIDS emerged in the early 1980s in several widely separated locations, including the United States, Haiti, Belgium, France, Zaire and Zambia. The…